Showing results (291-300 of 548) with videos related to

Sort By:
Pageof 55
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2009
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behaviorStephen D Mague, Carolina Isiegas, Peng Huang, et al.
International Journal of Molecular Sciences|September 10, 2021
Recent Advanced Metabolic and Genetic Engineering of Phenylpropanoid Biosynthetic PathwaysMuhammad Anwar, Liu Chen, Yibo Xiao, et al.
Infection and Drug Resistance|December 22, 2022
Correlation Between Drug Resistance and Virulence of Candida Isolates from Patients with CandidiasisZhiya Yang, Fangfang Zhang, Dongmei Li, et al.
Drug and Alcohol Dependence|June 25, 2017
Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent ratsHelene L Philogene-Khalid, Callum Hicks, Allen B Reitz, et al.
Annals of Translational Medicine|November 9, 2019
The SGLT2 inhibitor dapagliflozin attenuates the activity of ROS-NLRP3 inflammasome axis in steatohepatitis with diabetes mellitusWeiling Leng, Mingxia Wu, Hang Pan, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2009
Synthesis and biological evaluation of C-12 triazole and oxadiazole analogs of salvinorin ALu Yang, Wei Xu, Feng Chen, et al.
Gut Microbes|December 4, 2023
Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic reviewSusanna Meade, Jeremy Liu Chen Kiow, Cristian Massaro, et al.
Molecular Immunology|July 17, 2024
Mycobacterium vaccae attenuates airway inflammation by inhibiting autophagy and activating PI3K/Akt signaling pathway in OVA-induced allergic airway inflammation mouse modelHuan Xiao, An-Zhou Tang, Mei-Li Xu, et al.
Nucleic Acids Research|April 30, 2022
NASP maintains histone H3-H4 homeostasis through two distinct H3 binding modesHongyu Bao, Massimo Carraro, Valentin Flury, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 7, 2025
Synthetic control methods for n-of-1 and parallel-group trials in Alzheimer's disease: A proof-of-concept study using the I-CONECTChao-Yi Wu, Liu Chen, John R Dickson, et al.
Pageof 55